Kalytera Issues CEO Letter to Shareholders
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
Email Alerts
Subscribe to Receive Email Alerts
Get Important News and Developments by Email
Fill out my
online form
.
Contact Us
Kalytera Therapeutics, Inc.
41 Thunderbird Drive
Novato, CA 94949
info@kalytera.co
(888) 861-2008
